Remedinet Technologies Private Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Remedinet Technologies Private Limited - overview

Established

2006

Location

Bangalore, Karnataka, India

Primary Industry

Software

About

Remedinet Technologies provides innovative digital solutions designed to enhance the efficiency of healthcare insurance processes by bridging the gap between payers and providers, ensuring streamlined operations in claims management and preauthorization. Founded in 2006 and headquartered in Bangalore, India, Remedinet Technologies specializes in digital solutions for healthcare insurance. The company has undergone various strategic developments, including securing investment from Bessemer Venture Partners and Nirvana Venture Advisors, which contributed to a total funding of INR 60. 00 mn by June 2016.


Munish Daga is the CEO, leading the company through its evolution in the healthcare technology space. Remedinet specializes in providing comprehensive digital solutions tailored for the healthcare insurance industry, primarily focusing on streamlining operations between payers and providers. Its core product offerings include the Electronic Preauthorization Manager (EPM), Electronic Claims Manager (ECM), Electronic Discharge Manager (EDM), Chief Financial Officer Dashboard, and various automation suites designed for health insurance claims and management. The EPM facilitates the submission of structured electronic forms to payers, ensuring data legibility and accuracy, while the ECM allows healthcare providers to upload hospitalization-related documents to expedite claims processing.


The EDM supports the discharge process for hospitalized patients by automating bill generation, eliminating manual paperwork. The company serves a diverse client base, including some of India’s largest healthcare institutions, and operates in various markets, addressing needs across government health insurance schemes, corporate self-funded schemes, and third-party administrators, primarily within India. In the most recent fiscal year 2023, Remedinet reported revenue of INR 1,470,592. 50 and an EBITDA of INR 12,550.


50, generating income through a subscription-based model for its suite of healthcare technology products, which include flagship tools like the EPM and ECM. Clients enter into agreements to streamline their healthcare insurance processes effectively, enhancing revenue cycle management and improving cash flow for healthcare facilities. Looking ahead, Remedinet is actively developing new products to further enhance its service offerings in healthcare technology. The company aims to expand its reach into new markets, particularly targeting regions outside of India by 2025.


The recent funding of INR 60. 00 mn raised in June 2016 will be utilized to support these initiatives, enhancing product development and market entry strategies.


Current Investors

Volpi Capital, Bessemer Venture Partners, Nirvana Venture Advisors

Primary Industry

Software

Sub Industries

Accounting/Finance Software

Website

www.remedinet.com

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Remedinet Technologies Private Limited - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedRemedinet Technologies Private Limited-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.